Smith, Salley & Associates
- SEC CIK
- 0001482012
- Latest filing
- Jul 23, 2026
DNA holding history
Ginkgo Bioworks Holdings, Inc. in every 13F filed by Smith, Salley & Associates, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DNA overviewAll 13F holders of DNAFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −1,350−100.0% | Sold outConverted for a 1-for-40 split | Holders |
| Q2 2024 | 54,000 | $18.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 54,000 | $62.6K | <0.1% | +30,000+125.0% | Added | Holders |
| Q4 2023 | 24,000 | $40.6K | <0.1% | +12,000+100.0% | Added | Holders |
| Q3 2023 | 12,000 | $21.7K | <0.1% | +12,000 | New | Holders |